Anavex Life Sciences Corp (AVXL)

[Gator328]

Anavex could charge $1500/year and there would still be billions of dollars of profit over the lifetime of the drug for shareholders to enjoy. The attempt to curb skyrocketing drug prices is a step in the right direction that will benefit the majority of citizens, which ought to be the objective of any functional government.

Blarcamesine is by all accounts comparatively inexpensive to produce. The childish response is actually using logical fallacy to reduce Blarcamesine's revenue generating potential to an all-or-none scenario. It's possible to make a profit without the company looking like a bunch of greedy a**h*les. Otherwise, that makes us no better than Martin Shkreli.